U.S. Markets open in 6 hrs 22 mins

GlaxoSmithKline’s Recent 3Q17 Developments

Mike Benson

On September 27, 2017, the Japanese Ministry of Health, Labour and Welfare approved Benlysta for the treatment of systemic lupus erythematosus in patients not cured with existing therapies.